chr11-124023481-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001953.1(OR10G9):āc.469G>Cā(p.Val157Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,613,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001953.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10G9 | NM_001001953.1 | c.469G>C | p.Val157Leu | missense_variant | 1/1 | ENST00000375024.1 | NP_001001953.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10G9 | ENST00000375024.1 | c.469G>C | p.Val157Leu | missense_variant | 1/1 | NM_001001953.1 | ENSP00000364164 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 151830Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 251034Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135652
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461668Hom.: 0 Cov.: 66 AF XY: 0.0000124 AC XY: 9AN XY: 727146
GnomAD4 genome AF: 0.000263 AC: 40AN: 151950Hom.: 0 Cov.: 30 AF XY: 0.000269 AC XY: 20AN XY: 74262
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.469G>C (p.V157L) alteration is located in exon 1 (coding exon 1) of the OR10G9 gene. This alteration results from a G to C substitution at nucleotide position 469, causing the valine (V) at amino acid position 157 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at